Rodríguez-Garza Nancy E, Marín Miguel, Sánchez-Montejo Javier, Elizondo-Luévano Joel H, Bazaldúa-Rodríguez Aldo F, Quintanilla-Licea Ramiro, Romo-Sáenz César I, Peláez Rafael, Muro Antonio, López-Abán Julio
Grupo de Enfermedades Infecciosas y Tropicales (e-INTRO), Instituto de Investigación Biomédica de Salamanca, Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (IBSAL-CIETUS), Facultad de Farmacia, Universidad de Salamanca, 37007 Salamanca, Spain.
Departamento de Microbiología e Inmunología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66455, Nuevo León, Mexico.
Pathogens. 2025 Apr 25;14(5):419. doi: 10.3390/pathogens14050419.
Parasitic diseases constitute a significant challenge to global public health, with ranking among the most prevalent and clinically significant parasites. The limitations of current nematocidal therapies highlight an urgent need for novel treatment strategies. In this study, the nematocidal activity of chalepensin and graveoline, two compounds isolated from , was evaluated against larval and adult stages of (model for ). The in vitro efficacy of these compounds was assessed on third-stage infective larvae (L3) and adult parthenogenetic females at various time points, while cytotoxicity was determined using Vero cells to calculate selectivity indices (SI). Both compounds showed good antiparasitic activity, but chalepensin exhibited superior nematocidal activity compared to graveoline, with an LC of 3.9 µg/mL and an SI of 990 for L3, and an LC of 16.8 µg/mL and an SI of 200 for adult females at 72 h. Morphological analysis via scanning electron microscopy in adult females revealed that graveoline induced mostly cuticle detachment, while chalepensin caused protuberances across the parasite body. These findings suggest that both compounds possess promising antiparasitic potential, with chalepensin emerging as a particularly potent candidate for further exploration.
寄生虫病对全球公共卫生构成重大挑战,[寄生虫名称]是最普遍且具有临床重要性的寄生虫之一。当前杀线虫疗法的局限性凸显了对新型治疗策略的迫切需求。在本研究中,评估了从[植物名称]中分离出的两种化合物chalepensin和graveoline对[寄生虫名称]([某种寄生虫的模型])幼虫和成虫阶段的杀线虫活性。在不同时间点评估了这些化合物对第三期感染性幼虫(L3)和孤雌生殖成年雌虫的体外疗效,同时使用Vero细胞测定细胞毒性以计算选择性指数(SI)。两种化合物均显示出良好的抗寄生虫活性,但与graveoline相比,chalepensin表现出更强的杀线虫活性,对L3的LC50为3.9 µg/mL,SI为990;对成年雌虫在72小时时的LC50为16.8 µg/mL,SI为200。通过扫描电子显微镜对成年雌虫进行的形态学分析表明,graveoline主要诱导表皮脱落,而chalepensin导致寄生虫身体出现突起。这些发现表明这两种化合物都具有有前景的抗寄生虫潜力,chalepensin成为进一步探索特别有潜力的候选物。
需注意,原文中部分关键信息未完整给出,如具体寄生虫名称、植物名称等,翻译时用[具体名称]表示以便理解大致结构,实际应用中应根据完整准确信息进行完善。